fbpx Pubblicazioni in evidenza | Istituto di Candiolo - FPO - IRCCS
Cell Metabolism Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies
Lancet Oncology TOMAS: an open-label, phase 1b study from the Italian Sarcoma Group.
Jci Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies
Cancer Research High USP6NL Levels in Breast Cancer Sustain Chronic AKT Phosphorylation and GLUT1 Stability Fueling Aerobic Glycolysis
Nature Communications Article | OPEN | Published: 12 June 2018 Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies
Science Translational Medicine A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent
Lancet Oncology Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
Cancer Discovery MET-driven resistance to dual EGFR and BRAF blockade may be overcome by switching from EGFR to MET inhibition in BRAF mutated colorectal cancer
Nature The genomic landscape of response to EGFR blockade in colorectal cancer
Nat Med. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

 

Raggiungi l'Istituto di Candiolo

 

  •  Indirizzo per navigatori: Strada Provinciale 142 di Piobesi incrocio Strada Statale 23 del Sestriere  -  Coordinate: 44°58'01.6"N 7°34'00.0"E